BioNTech completes phase-II trial of COVID-19 vaccine in China Reuters May 11, 2022 The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to…
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine EP News Bureau Feb 24, 2022 Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralising antibodies 18-to 30-fold across…
China’s potential mRNA COVID vaccine weaker against Omicron: Study Reuters Feb 16, 2022 The vaccine is being tested in an international phase-III clinical trial
Leiden University Medica Center and Intravacc to start clinical trial with new intranasal corona… EP News Bureau Jan 6, 2022 Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteins